Article
Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment.
Journal of women's health & gender-based medicine - 1 Apr 2000
Tambor E S, Bernhardt B A, Geller G, Helzlsouer K J, Doksum T, Holtzman N A
Abstract excerpt
More information is needed about the relative effectiveness of prophylactic surgery, chemoprevention, and surveillance in reducing breast and ovarian cancer risk in women with an inherited susceptibility mutation. We assessed practical and ethical barriers to conducting randomized clinical trials (RCTs) to compare preventive interventions for breast and ovarian cancer. Eighty-seven at-risk women who attended an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
